Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. [electronic resource]
Producer: 20050111Description: 621-32 p. digitalISSN:- 1535-7163
- Antibiotics, Antineoplastic -- pharmacology
- Ataxia Telangiectasia Mutated Proteins
- Caffeine -- pharmacology
- Camptothecin -- antagonists & inhibitors
- Cell Cycle -- drug effects
- Cell Cycle Proteins -- metabolism
- Cell Death -- drug effects
- Cell Line, Tumor
- DNA Damage -- drug effects
- DNA-Binding Proteins
- Dose-Response Relationship, Drug
- Doxorubicin -- antagonists & inhibitors
- Enzyme Inhibitors -- pharmacology
- G1 Phase -- drug effects
- G2 Phase -- drug effects
- Genes, cdc -- drug effects
- Guanine Nucleotide Exchange Factors -- metabolism
- Humans
- Nuclear Proteins -- metabolism
- Protein Serine-Threonine Kinases -- deficiency
- S Phase -- drug effects
- Topoisomerase I Inhibitors
- Topoisomerase II Inhibitors
- Tumor Suppressor Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.